Status:
UNKNOWN
Surgical Treatment and Molecular Marker Exploration of Locally Recurrent Colorectal Cancer
Lead Sponsor:
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Conditions:
Locally Recurrent Colorectal Cancer
Eligibility:
All Genders
18-85 years
Brief Summary
This study intends to explore the clinicopathological characteristics and survival prognosis of locally recurrent colorectal cancer patients with different treatment modes by retrospectively analyzing...
Detailed Description
In the past few decades, although the widespread implementation of total mesorectal excision (TME) and neoadjuvant chemoradiotherapy has dramatically reduced the postoperative local recurrence rate of...
Eligibility Criteria
Inclusion
- Patients with LRCRC who received hospitalization in our center and patients with stage II-III colorectal cancer whose primary surgery was radical surgery
- The pathological type of primary tumor is adenocarcinoma
- Postoperative local recurrence of colorectal cancer diagnosed by imaging or pathological examination
- Have complete medical records and continuous follow-up records
Exclusion
- Familial hereditary colorectal malignant tumors
- Past history of other malignant tumors
- Recurrence and diffuse peritoneal recurrence occurring within 1 month after surgery
Key Trial Info
Start Date :
January 30 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06114420
Start Date
January 30 2023
End Date
December 31 2025
Last Update
November 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
Beijing, Beijing Municipality, China, 100021